节律制药 RYTM
$112.28 +$7.26 (+6.91%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $112.80 +0.46%
开盘$107.10
昨收$105.02
当日区间$104.31 – $113.29
成交量4.94M
市值$7.78B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数15
平均目标价$146.38+30.4% 较现价
- 买入 93%
- 持有 7%
最低 $120.00现价 $112.28均值 $146.38最高 $206.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$120.00至$206.00，平均为$148.41。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 28 Oct 2026 | Citi | BUY | $143.00 |
| 19 Oct 2026 | Guggenheim | BUY | $143.00 |
| 15 Oct 2026 | William Blair | BUY | $206.00 |
| 15 Oct 2026 | J.P. Morgan | BUY | $145.00 |
| 14 Oct 2026 | Citi | BUY | $143.00 |
| 12 Oct 2026 | H.C. Wainwright | BUY | $130.00 |
| 9 Oct 2026 | BofA Securities | BUY | – |
| 8 Oct 2026 | RBC Capital | BUY | $159.00 |
| 17 Sep 2026 | Wolfe Research | BUY | – |
| 15 Sep 2026 | J.P. Morgan | BUY | – |
| 14 Sep 2026 | Leerink Partners | BUY | $133.00 |
| 14 Sep 2026 | RBC Capital | BUY | $155.00 |
| 27 Aug 2026 | Deutsche Bank | HOLD | $120.00 |
| 24 Aug 2026 | Morgan Stanley | BUY | $150.00 |
| 24 Aug 2026 | Guggenheim | BUY | $143.00 |
| 10 Aug 2026 | J.P. Morgan | BUY | $146.00 |
| 5 Aug 2026 | CCORF | BUY | $154.00 |
| 5 Aug 2026 | Citizens JMP | BUY | $160.00 |
| 5 Aug 2026 | Morgan Stanley | BUY | $150.00 |
| 5 Aug 2026 | Citi | BUY | $143.00 |
暂无评论——快来第一个聊聊 RYTM。
登录后参与讨论。